title: [Thrombotic thrombocytopenic purpura: the need of an early treatment].
abstract: Two patients affected by thrombotic thrombocytopenic purpura (TTP) are treated with plasmapheresis, fresh frozen plasma infusion, steroid and inhibitors of platelet aggregation with an impaired final stage: the first patient died during a plasmapheresis session and the other had a good evolution, obtaining complete recovery, maintained a year later. We discuss the clinical features and highlight the needs for early treatment with all the latest therapies.
authors.forename: J
authors.initials: J
authors.lastname: García Castaño
authors.forename: B
authors.initials: B
authors.lastname: Pinilla Llorente
authors.forename: J M
authors.initials: JM
authors.lastname: García Román
authors.forename: A
authors.initials: A
authors.lastname: Rollán Landeras
authors.forename: E
authors.initials: E
authors.lastname: Sánchez Sánchez
authors.forename: C
authors.initials: C
authors.lastname: Gilsanz Fernández
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008875:Middle Aged; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy*; D013997:Time Factors
vernacular_title: Púpura trombocitopénica trombótica: necesidad de un tratamiento precoz.